Please login to the form below

uterine fibroids

This page shows the latest uterine fibroids news and features for those working in and with pharma, biotech and healthcare.

Bayer extends alliance with Evotec in women’s health

The lead candidate from the endometriosis alliance is vilaprisan, which has advanced into phase 2 trials in both endometriosis and uterine fibroids but suffered a setback at the end of 2018,

Latest news

Myovant preps US filing for relugolix in prostate cancer

Myovant is in a head-to-head battle with AbbVie and its rival GnRH inhibitor Orilissa (elagolix) in endometriosis-related pain and uterine fibroids, but has a clear run at the ... cancer”. It’s also an important development as Myovant has delayed
AbbVie files blockbuster hopeful elagolix for uterine fibroids

Will face competition from Myovant rival. AbbVie is gunning for the second indication for its new women’s health product Orilissa, hoping to add uterine fibroids to its FDA approval last ... That raises the question of whether women will be prepared to
Myovant has second phase 3 trial to back its uterine fibroids drug

and was due to be filed for the uterine fibroids indication right about now, giving it a few months’ head start. ... Analysts suggest that uterine fibroids could be a $1bn-plus market for GnRH antagonists.
Myovant’s fibroids drug clears phase 3 trial, but shares sink

Uterine fibroids are non-cancerous tumours that form in the muscle walls of the uterus and affect between 20% and 80% of women by the age of 50. ... Their drug is already approved as Orilissa to treat endometriosis and has two positive phase 3 readouts
Urovant slips on phase 3 incontinence drug data

Others cued up for results include phase 3 trials of Myovant’s relugolix in uterine fibroids, endometriosis and prostate cancer, and Dermavant’s tapinarof in psoriasis.

More from news
Approximately 5 fully matching, plus 23 partially matching documents found.

Latest from PMHub

July 2020: diversity and inclusion in clinical trials round-up

Dr. Charlotte Owens, an OB-GYN and medical director of AbbVie, has completed successful clinical trials on uterine fibroids with a high representation of Black women, and outlines the key steps

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Medical Editor: Competitive

Healthcare Senior Account Manager: Competitive

Healthcare Lead Copywriter: Competitive

Account Director – Creative Healthcare Communications: Competative

Healthcare Account Director: Competitive

PMHub

Add my company

Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
Three ways AI will change healthcare in the next decade: Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...